Gisela Paulsen's Insider Trades & SAST Disclosures

Gisela Paulsen's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 175,000 Common Stock, no par value done . Disclosure was reported to the exchange on Dec. 16, 2022.

Share

Note

This is a custom search result for pattern Gisela Paulsen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Insight Molecular Diagnost...	Gisela Paulsen	Former President and COO	Sale or transfer of securities back to the company at price $ 0.00 per share.	16 Dec 2022	175,000	366,500 (0%)	0%		0	Common Stock, no par value
Insight Molecular Diagnost...	Gisela Paulsen	Former President and COO	Sale or transfer of securities back to the company at price $ 0.00 per share.	16 Dec 2022	171,875	203,125	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	Gisela Paulsen	Former President and COO	Sale or transfer of securities back to the company at price $ 0.00 per share.	16 Dec 2022	125,000	0	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	Gisela Paulsen	Former President and COO	Sale or transfer of securities back to the company at price $ 0.00 per share.	16 Dec 2022	70,313	54,687	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	Gisela Paulsen	President & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Aug 2022	350,000	541,500 (0%)	0%		0	Common Stock, no par value
Insight Molecular Diagnost...	Gisela Paulsen	President & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Aug 2022	175,000	191,500 (0%)	0%		0	Common Stock, no par value
Insight Molecular Diagnost...	Gisela Paulsen	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2022	125,000	125,000	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	Gisela Paulsen	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2022	125,000	125,000	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	Gisela Paulsen	Chief Operating Officer	Purchase of securities on an exchange or from another person at price $ 1.20 per share.	15 Mar 2022	16,500	16,500 (0%)	0%	1.2	19,767	Common Stock, no par value

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades